Table 3.
Comparative analysis according to the intraoperative assessment results, n = 222
| IOA negative | IOA positive | P | |
|---|---|---|---|
| 142 (64%) | 80 (36%) | ||
| Agea | 53.7 ± 11.4 | 56 ± 12.2 | 0.166 |
| Menopause | 108 (76%) | 62 (77.5%) | 0.807 |
| Weight, kgb | 74.5 (65.5-85.5) | 68.5 (60-80.5) | 0.079 |
| BMIa | 32.6 ± 6.7 | 31.1 ± 7.1 | 0.131 |
| Surgical stage | |||
| I | 120 (84.5%) | 42 (52.5%) | < 0.001 |
| II | 12 (8.5%) | 13 (16.3%) | |
| III | 8 (5.6%) | 22 (27.5%) | |
| IV | 2 (1.4%) | 3 (3.8%) | |
| Lymph node metastasis | 7 (4.9%) | 16 (20%) | < 0.001 |
| Lymphadenectomy | 18 (12.7%) | 69 (86.3%) | < 0.001 |
| Bleeding, mlb | 150 (80-300) | 375 (200-550) | < 0.001 |
| Transfusion | 0 (0%) | 8 (10%) | < 0.001 |
| Reintervention | 2 (1.4%) | 3 (3.8%) | 0.277 |
| ICU | 2 (1.4%) | 5 (6.3%) | 0.07 |
| Adjuvant therapy | 44 (31%) | 62 (77.5%) | < 0.001 |
| Radiotherapy | 41 (28.9%) | 58 (72.5%) | 0.94 |
| Chemotherapy | 8 (5.6%) | 22 (27.5%) | 0.049 |
| Recurrence of disease | 7 (4.9%) | 8 (10%) | 0.156 |
FSB frozen section biopsy, BMI body mass index, ICU intensive care unit, IOA intraoperative assessment
aMean ± standard deviation
bMedian (interquartile range)